CARA — Cara Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $18.84m
- -$50.94m
- $20.97m
- 26
- 56
- 18
- 25
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 155 | 181 | 167 | 145 | 101 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.79 | 2.06 | 1.15 | 4.45 | 4.02 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 166 | 195 | 173 | 169 | 116 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 3.74 | 5.12 | 3.6 | 1.98 | 8.19 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 233 | 271 | 247 | 182 | 126 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 42.9 | 18.5 | 17.6 | 23.5 | 25.6 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 46.2 | 22.2 | 19.5 | 23.5 | 68.8 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 187 | 249 | 228 | 159 | 57.1 |
Total Liabilities & Shareholders' Equity | 233 | 271 | 247 | 182 | 126 |
Total Common Shares Outstanding |